Literature DB >> 25213343

Secular trends in ischemic stroke subtypes and stroke risk factors.

Chrysi Bogiatzi1, Daniel G Hackam1, A Ian McLeod1, J David Spence2.   

Abstract

BACKGROUND AND
PURPOSE: Early diagnosis and treatment of a stroke improves patient outcomes, and knowledge of the cause of the initial event is crucial to identification of the appropriate therapy to maximally reduce risk of recurrence. Assumptions based on historical frequency of ischemic subtypes may need revision if stroke subtypes are changing as a result of recent changes in therapy, such as increased use of statins.
METHODS: We analyzed secular trends in stroke risk factors and ischemic stroke subtypes among patients with transient ischemic attack or minor or moderate stroke referred to an urgent transient ischemic attack clinic from 2002 to 2012.
RESULTS: There was a significant decline in low-density lipoprotein cholesterol and blood pressure, associated with a significant decline in large artery stroke and small vessel stroke. The proportion of cardioembolic stroke increased from 26% in 2002 to 56% in 2012 (P<0.05 for trend). Trends remained significant after adjusting for population change.
CONCLUSIONS: With more intensive medical management in the community, a significant decrease in atherosclerotic risk factors was observed, with a significant decline in stroke/transient ischemic attack caused by large artery atherosclerosis and small vessel disease. As a result, cardioembolic stroke/transient ischemic attack has increased significantly. Our findings suggest that more intensive investigation for cardiac sources of embolism and greater use of anticoagulation may be warranted.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  epidemiology; secondary prevention; stroke etiology; trends

Mesh:

Substances:

Year:  2014        PMID: 25213343     DOI: 10.1161/STROKEAHA.114.006536

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  31 in total

Review 1.  Cardioembolic Stroke.

Authors:  Hooman Kamel; Jeff S Healey
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 2.  Management of Patients with an Asymptomatic Carotid Stenosis--Medical Management, Endovascular Treatment, or Carotid Endarterectomy?

Authors:  J David Spence
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

3.  Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study).

Authors:  Hooman Kamel; Traci M Bartz; Mitchell S V Elkind; Peter M Okin; Evan L Thacker; Kristen K Patton; Phyllis K Stein; Christopher R deFilippi; Rebecca F Gottesman; Susan R Heckbert; Richard A Kronmal; Elsayed Z Soliman; W T Longstreth
Journal:  Stroke       Date:  2018-03-13       Impact factor: 7.914

Review 4.  Non-vitamin K antagonist oral anticoagulants for the treatment of intracardiac thrombosis.

Authors:  Eiman Ghaffarpasand; Maneli D Tehrani; Jolanta Marszalek; Gerald Chi
Journal:  J Thromb Thrombolysis       Date:  2018-10       Impact factor: 2.300

5.  Bioinformatic analysis for potential biological processes and key targets of heart failure-related stroke.

Authors:  Chiyu Liu; Sixu Chen; Haifeng Zhang; Yangxin Chen; Qingyuan Gao; Zhiteng Chen; Zhaoyu Liu; Jingfeng Wang
Journal:  J Zhejiang Univ Sci B       Date:  2021 Sept 15       Impact factor: 3.066

Review 6.  Promising Biomarker Candidates for Cardioembolic Stroke Etiology. A Brief Narrative Review and Current Opinion.

Authors:  Arnold Markus; Schütz Valerie; Katan Mira
Journal:  Front Neurol       Date:  2021-02-25       Impact factor: 4.003

Review 7.  Interleukin-1 and acute brain injury.

Authors:  Katie N Murray; Adrian R Parry-Jones; Stuart M Allan
Journal:  Front Cell Neurosci       Date:  2015-02-06       Impact factor: 5.505

Review 8.  Action mechanism and cardiovascular effect of anthocyanins: a systematic review of animal and human studies.

Authors:  Jordano Ferreira Reis; Valter Vinicius Silva Monteiro; Rafaelli de Souza Gomes; Matheus Moraes do Carmo; Glauber Vilhena da Costa; Paula Cardoso Ribera; Marta Chagas Monteiro
Journal:  J Transl Med       Date:  2016-11-15       Impact factor: 5.531

9.  Comparison of the Chinese ischemic stroke subclassification and Trial of Org 10172 in acute stroke treatment systems in minor stroke.

Authors:  Sha Tan; Lei Zhang; Xiaoyu Chen; Yanqiang Wang; Yinyao Lin; Wei Cai; Yilong Shan; Wei Qiu; Xueqiang Hu; Zhengqi Lu
Journal:  BMC Neurol       Date:  2016-09-06       Impact factor: 2.474

10.  Risk Factors, Regional Disparity and Trends of Ischemic Stroke Etiologic Subtypes.

Authors:  Dan-Yang Tian; Dong-Sheng Fan
Journal:  Chin Med J (Engl)       Date:  2018-01-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.